In Vitro and In Vivo Evaluation of (89)Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy

Background: DS-8273a, an anti-human death receptor 5 (DR5) agonistic antibody, has cytotoxic activity against human cancer cells and induces apoptosis after specific binding to DR5. DS-8273a is currently being used in clinical Phase I trials. This study evaluated the molecular imaging of DR5 express...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Burvenich, Ingrid J.G., Lee, Fook-Thean, Guo, Nancy, Gan, Hui K., Rigopoulos, Angela, Parslow, Adam C., O'Keefe, Graeme J., Gong, Sylvia J., Tochon-Danguy, Henri, Rudd, Stacey E., Donnelly, Paul S., Kotsuma, Masakatsu, Ohtsuka, Toshiaki, Senaldi, Giorgio, Scott, Andrew M.
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135445/
https://ncbi.nlm.nih.gov/pubmed/27924159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.16260
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados